News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,483 Results
Type
Article (39440)
Company Profile (249)
Press Release (653794)
Section
Business (204071)
Career Advice (2006)
Deals (35409)
Drug Delivery (93)
Drug Development (80961)
Employer Resources (169)
FDA (16138)
Job Trends (14832)
News (344944)
Policy (32480)
Tag
Academia (2539)
Alliances (49334)
Alzheimer's disease (1317)
Approvals (16124)
Artificial intelligence (208)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (177)
Breast cancer (230)
Cancer (1767)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (128)
Cell therapy (368)
Clinical research (65342)
Collaboration (687)
Compensation (379)
COVID-19 (2568)
C-suite (171)
Data (1686)
Diabetes (220)
Diagnostics (6301)
Earnings (85644)
Employer resources (145)
Events (111096)
Executive appointments (583)
FDA (17076)
Funding (617)
Gene therapy (252)
GLP-1 (657)
Government (4362)
Healthcare (18786)
Infectious disease (2685)
Interviews (311)
IPO (16466)
Job creations (3628)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (258)
Manufacturing (241)
Medical device (13276)
Medtech (13281)
Mergers & acquisitions (19333)
Metabolic disorders (570)
Neuroscience (1733)
NextGen: Class of 2025 (6512)
Non-profit (4481)
Northern California (2174)
Obesity (313)
Opinion (197)
Patents (174)
People (56907)
Phase I (20346)
Phase II (28782)
Phase III (21432)
Pipeline (779)
Postmarket research (2563)
Preclinical (8586)
Radiopharmaceuticals (242)
Rare diseases (330)
Real estate (5897)
Regulatory (21973)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1862)
Startups (3571)
United States (19106)
Vaccines (620)
Weight loss (213)
Date
Today (74)
Last 7 days (803)
Last 30 days (2651)
Last 365 days (34305)
2025 (5299)
2024 (35221)
2023 (40077)
2022 (51174)
2021 (55713)
2020 (54087)
2019 (46545)
2018 (35026)
2017 (32114)
2016 (31482)
2015 (37558)
2014 (31322)
2013 (26349)
2012 (28573)
2011 (29273)
2010 (27332)
Location
Africa (717)
Arizona (211)
Asia (37545)
Australia (6139)
California (4951)
Canada (1746)
China (410)
Colorado (225)
Connecticut (234)
Europe (80493)
Florida (730)
Georgia (171)
Illinois (463)
Indiana (270)
Japan (126)
Maryland (757)
Massachusetts (3764)
Michigan (200)
Minnesota (344)
New Jersey (1401)
New York (1416)
North Carolina (853)
Northern California (2174)
Ohio (174)
Pennsylvania (1128)
South America (1093)
Southern California (1862)
Texas (725)
Utah (153)
Washington State (474)
693,483 Results for "beckman coulter inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Beckman Coulter Receives FDA Breakthrough Device Designation for Alzheimer’s Disease Blood Test
January 29, 2025
·
4 min read
Press Releases
Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research
January 16, 2025
·
5 min read
Policy
Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
Beckman Coulter, a global leader in clinical diagnostics, announced U.S. Food and Drug Administration clearance of its Access NT-proBNP assay for the assessment of heart failure in less than 11 minutes on the Beckman Coulter DxI 9000 Immunoassay Analyzer*.
May 29, 2024
·
3 min read
Business
Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced expansion of their host immune response diagnostics partnership.
May 7, 2024
·
5 min read
Beckman Coulter’s DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced , ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases, that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays.
April 16, 2024
·
4 min read
Press Releases
BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests
October 29, 2024
·
4 min read
Business
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics - March 12, 2024
Beckman Coulter Diagnostics today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
March 12, 2024
·
4 min read
Press Releases
Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care
October 9, 2024
·
4 min read
Business
Beckman Coulter Diagnostics Appoints Kevin O’Reilly as New President
Beckman Coulter Diagnostics announced Kevin O’Reilly’s appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive, Danaher Diagnostics.
February 6, 2024
·
3 min read
Biotech Beach
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic manufacturing, announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
March 12, 2024
·
4 min read
1 of 69,349
Next
